Copyright: ©Author(s) 2026.
World J Transplant. Jun 18, 2026; 16(2): 118012
Published online Jun 18, 2026. doi: 10.5500/wjt.v16.i2.118012
Published online Jun 18, 2026. doi: 10.5500/wjt.v16.i2.118012
Figure 1 Dynamic immune dysfunction and vaccination responsiveness across cirrhosis and liver transplantation.
ACLF: Acute-on-chronic liver failure; CAID: Cirrhosis-associated immune dysfunction; CNI: Calcineurin inhibitor; IS: Immunosuppression; LT: Liver transplantation; MASLD: Metabolic dysfunction-associated steatotic liver disease; MELD: Model for end-stage liver disease; MMF: Mycophenolate mofetil.
Figure 2 Timing matters: When to vaccinate liver transplant candidates and recipients? HAV: Hepatitis A virus; HPV: Human papillomavirus; MMR: Measles, mumps, and rubella; LT: Liver transplantation; LAIV: Live attenuated influenza vaccine.
Figure 3 Strategies to overcome the vaccine immunogenicity gap in liver transplant recipients.
LT: Liver transplantation; MMF: Mycophenolate mofetil; IS: Immunosuppression; IGRA: Interferon-gamma release assay.
- Citation: Papic N, Kosuta I, Ljubas D, Vrsaljko N, Sesa V, Domislovic V, Ahsan S, Mrzljak A. Not just another shot: Tailoring vaccination in the era of modern liver transplantation. World J Transplant 2026; 16(2): 118012
- URL: https://www.wjgnet.com/2220-3230/full/v16/i2/118012.htm
- DOI: https://dx.doi.org/10.5500/wjt.v16.i2.118012